Adamas to Present at Upcoming BofA Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on May 11, 2021.
The fireside chat will be webcast live on Tuesday, May 11, 2021 at 11:45 am Eastern Time on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replay will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005319/en/
Media:
Sarah Mathieson
Vice President, Corporate Communications
510-450-3528
[email protected]
Investors:
Peter Vozzo
Managing Director
Westwicke/ICR
443-213-0505
[email protected]
KEYWORDS: California United States North America
INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Mental Health
MEDIA:
| Logo |
 |